VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
ARCC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ARCCAres Capital Corporation
$19.64$14.1B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksARCCBalance Sheet

Ares Capital Corporation (ARCC) Balance Sheet

22Y historyFree accessUpdated daily

Total assets contracted 2.2% to $30.5B in 2026Q2, while equity/assets held at 0.46, but cash reserves dropped 58.5% to $383M and investment securities were reported as zero, suggesting potential valuation gaps.

ARCC Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04
Cash & Short Term Investments2.85B924M635M535M303M372M254M176M296M316M223M257.06B194.56M149.63M269.04M120.78M100.75M99.23M89.38M1.8B91.54M16.61M26.81M
Cash & Due from Banks383M924M635M535M303M372M254M176M296M316M223M257M194.56M149.63M269.04M120.78M100.75M99.23M89.38M21.14M91.54M16.61M26.81M
Short Term Investments00000000000504K00000001.77B000
Total Investments029.48B26.72B22.89B21.78B20.01B15.52B14.43B12.42B11.84B8.82B9.06B9.03B7.63B5.92B5.09B4.32B2.17B1.97B3.55B1.24B585.97M182.56M
Investments Growth %0%10.34%16.75%5.09%8.85%28.97%7.55%16.18%4.86%34.25%-2.61%0.31%18.28%28.83%16.29%17.98%98.82%10.08%-44.4%187.13%110.9%220.97%-
Long-Term Investments29.48B29.48B26.72B22.89B21.78B20.01B15.52B14.43B12.42B11.84B8.82B9.06B9.03B7.63B5.92B5.09B4.32B2.17B1.97B1.77B1.24B585.97M182.56M
Accounts Receivables299M605M516M261M180M222M223M00000000550K8.88M03K1.34M1.03M5.83M0
Goodwill & Intangibles00000000000000000000000
Goodwill00000000000000000000000
Intangible Assets00000000000000000000000
PP&E (Net)000020M27M38M94M000000000000000
Other Assets0144M381M86M81M99M94M-14.43B-12.42B-11.84B-8.82B0000062.38M-40.7M11.42M-159-1.24B-585.97M-182.56M
Total Current Assets682M1.53B1.15B825M517M708M549M307M399M409M335M395.03B357.93M402.18M378.17M292.93M182.18M127.25M106.93M46.22M101.66M22.44M27.95M
Total Non-Current Assets029.63B27.1B22.98B21.88B20.14B15.65B94M12.42B11.84B8.82B9.06B9.03B7.63B5.92B5.09B4.38B2.13B1.98B1.77B1.24B585.97M182.56M
Total Assets30.5B31.23B28.25B23.8B22.4B20.84B16.2B14.9B12.89B12.35B9.24B9.53B9.5B8.14B6.4B5.39B4.56B2.31B2.09B1.83B1.35B613.65M220.46M
Asset Growth %37.48%10.55%18.71%6.26%7.46%28.69%8.66%15.59%4.44%33.55%-3%0.35%16.66%27.19%18.82%18.08%97.21%10.62%14.32%35.71%119.67%178.35%-
Return on Assets (ROA)3.12%4.37%5.85%6.59%2.78%8.46%3.11%5.71%6.8%6.18%5.05%3.98%6.7%6.72%8.62%6.42%14.31%9.2%-7.11%5.72%9%10.4%1.51%
Accounts Payable086M406M115M87M307M66M177M155M245M102M113M129.03M111.58M85.42M74.07M81.11M19.67M54.68M10.29M64.07M20.08M1.93M
Total Debt015.99B13.76B11.95B12.38B11.16B8.6B7.09B5.21B4.85B3.87B4.14B3.92B2.99B2.2B2.07B1.38B969.47M908.79M681.5M482M18M55.5M
Net Debt-383M15.07B13.12B11.41B12.07B10.79B8.35B6.92B-296M-316M3.65B-257M3.73B2.84B-269.04M1.95B1.28B870.24M819.4M660.36M390.46M1.39M28.69M
Long-Term Debt015.99B13.76B10.62B11.54B11.09B8.51B7B00003.92B2.99B01.61B840.2M747.9M794.49M596.53M000
Short-Term Debt0001.33B807M20M27M00000000463M538.31M221.57M114.3M85M482M18M55.5M
Other Liabilities04M734M116M56M114M72M-4.6M000000000-252.57M00000
Total Current Liabilities0894M406M1.87B1.22B724M375M121M348M395M206M220M289.58M250.78M217.01M629.57M671.81M307.73M201.97M108.33M560.6M44.03M60.75M
Total Non-Current Liabilities71M16.02B14.49B10.73B11.63B11.25B8.64B7.09B5.21B4.85B3.87B4.14B3.92B2.99B2.2B1.61B840.2M495.32M794.49M596.53M000
Total Liabilities16.61B16.92B14.9B12.6B12.84B11.97B9.02B7.44B5.59B5.25B4.08B4.36B4.21B3.24B2.41B2.24B1.51B1.06B996.45M704.85M558.56M44.03M60.75M
Total Equity13.89B14.32B13.36B11.2B9.55B8.87B7.18B7.47B7.3B7.1B5.17B5.17B5.28B4.9B3.99B3.15B3.05B1.26B1.09B1.12B789.43M569.61M159.71M
Equity Growth %21.19%7.21%19.23%17.23%7.75%23.58%-3.9%2.29%2.85%37.43%-0.15%-2.1%7.73%22.97%26.72%3.17%142.51%14.89%-2.64%42.45%38.59%256.66%-
Equity / Assets (Capital Ratio)45.55%45.84%47.27%47.06%42.66%42.55%44.31%50.1%56.61%57.49%55.87%54.27%55.63%60.24%62.31%58.42%66.86%54.37%52.35%61.47%58.56%92.82%72.44%
Return on Equity (ROE)6.78%9.39%12.4%14.67%6.51%19.53%6.61%10.74%11.92%10.88%9.17%7.25%11.6%10.99%14.24%10.31%22.84%17.23%-12.57%9.49%12.99%11.9%2.08%
Book Value per Share19.3520.4821.4019.4818.4519.8816.9217.4917.1416.7016.4516.4517.3118.3717.3315.3617.2612.3012.2116.6217.9524.2514.43
Tangible BV per Share19.3520.4821.4019.4818.4519.8816.9217.4917.1416.7016.4516.4517.3118.3717.3315.3617.2612.3012.2116.6217.9524.2514.43
Common Stock1M1M1M1M1M0000000314K298K249K205K204K110K97K72.68K52.04K37.91K11.07K
Additional Paid-in Capital013.36B12.5B10.74B9.56B8.55B7.66B7.76B7.17B7.19B5.29B5.32B5.33B4.98B4.12B3.39B3.21B1.49B1.4B1.14B785.19M559.19M159.6M
Retained Earnings0958M852M462M-2M315M-480M-293M127M-94M37M-145M-199.51M-8.79M-27.91M-229.14M-11.34M3.14M-7.64M7M7.04M0-136.41K
Accumulated OCI000000000000154.86M95.49M101.1M026.04M-235.82M-293.54M-19.13M-2.85M00
Treasury Stock00000000000000000000000
Preferred Stock00000000000000000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

NII contraction and negative NIM

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Asset Growth Stalls Amid Earnings Pressure

Total assets peaked at $31.2B in 2025Q4 but contracted to $30.5B by 2026Q2, a 2.2% decline, as reported in the latest balance sheet data.

The balance sheet expanded steadily from $24.3B in 2024Q1 to $31.2B in 2025Q4, but the subsequent two quarters show a pullback, suggesting a pause in organic growth. The decline is driven by a reduction in cash and investment securities, while equity remains relatively stable, indicating that asset shrinkage is not accompanied by capital erosion. This may reflect a strategic deleveraging or a response to deteriorating net interest income, which turned negative in 2026Q2.

Deposit Base Not Disclosed, Funding Mix Uncertain

The loan-to-deposit ratio is not reported, and deposit data are absent, leaving the funding structure opaque, as per the provided balance sheet figures.

Without explicit deposit disclosures, the reliance on wholesale funding or secured borrowings cannot be directly assessed. The total liabilities of $16.6B in 2026Q2 are roughly flat quarter-over-quarter, but the composition remains unclear. Investors should monitor future filings for deposit breakdowns to evaluate the stability and cost of the funding base, especially given the negative NIM.

Zero Provisions Mask Potential Credit Risk

Loan loss provisions were reported as zero for all quarters, while net investment income turned negative in 2026Q2, according to the balance sheet data.

The absence of any provision for loan losses across ten quarters is notable, especially as the portfolio has grown and NII has deteriorated. This may indicate that credit losses have not yet materialized, but it could also suggest under-recognition of risk. The negative NII in 2026Q2, coupled with a $41M loan loss line, hints at possible credit stress that warrants closer scrutiny.

Equity Ratio Stable but Earnings Erode Buffer

Equity-to-assets ratio held at 0.46 in 2026Q2, unchanged from the prior quarter, but ROE fell to 1.2%, based on reported figures.

The equity ratio has remained remarkably stable around 0.46-0.49 over the past ten quarters, indicating a consistent capital structure. However, the sharp decline in ROE from 3.9% in 2024Q1 to 1.2% in 2026Q2 suggests that retained earnings are weakening, which could constrain future capital deployment. The stable equity ratio may be maintained through reduced asset growth rather than organic capital generation.

Cash Buffer Thins as Securities Vanish

Cash and bank balances fell to $383M in 2026Q2 from $924M in 2025Q4, a 58.5% drop, while investment securities were reported as zero, per the balance sheet.

The liquidity position appears to be tightening, with cash reserves nearly halved over two quarters. Investment securities were only reported in 2025Q4 at $29.5B, but are zero in other periods, which is inconsistent and may indicate data reporting gaps. The reliance on cash alone for liquidity is concerning, especially if wholesale funding markets become stressed.

Negative NIM Signals Rate Sensitivity

Net interest margin turned negative at -0.7% in 2026Q2, down from 1.5% a year earlier, as reported in the balance sheet data.

The swing to a negative NIM suggests that the cost of funding now exceeds the yield on assets, a critical inflection point. This may be driven by rising deposit costs or falling asset yields, but without a deposit breakdown, the exact driver is unclear. The efficiency ratio of 2.4% in 2026Q2, down from 4.1% in 2024Q4, indicates a severe loss of operating leverage, implying that the negative NIM is not offset by cost controls.

Unrealized Losses Could Amplify Risk

Investment securities were reported at $29.5B in 2025Q4 but zero in other quarters, suggesting potential data gaps or valuation issues, as per the balance sheet.

The inconsistency in investment securities reporting raises questions about the accuracy of the balance sheet. If the securities portfolio is actually held, unrealized losses may be masked, especially given the negative NIM. This could imply that the reported equity is overstated, and the true capital position may be weaker than it appears. Investors should seek clarification on the treatment of investment securities and any unrealized gains or losses.

ARCC — Frequently Asked Questions

Quick answers to the most common questions about buying ARCC stock.

What are the total assets of Ares Capital Corporation (ARCC)?

As of 2025, Ares Capital Corporation (ARCC) had total assets of $31.23B including $1.53B in current assets.

How much debt does Ares Capital Corporation (ARCC) have?

Ares Capital Corporation (ARCC) carries total debt of $15.99B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Ares Capital Corporation?

Ares Capital Corporation (ARCC) has total shareholders' equity (book value) of $14.32B ($20.48 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Ares Capital Corporation's current ratio and liquidity?

Ares Capital Corporation (ARCC) reported a current ratio of 1.71x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.